AbbVie Inc (NYSE:ABBV)

Wednesday’s trading has closed, but ABBV is being traded in the after-hours session. After-Hours quote »
57.23
Data as of 4:00pm ET
 -0.53 / -0.92%
Today’s Change
44.32
Today|||52-Week Range
60.02
+8.37%
Year-to-Date
AbbVie Announces Positive Results on Oncology Candidate - Analyst Blog
5:07pm / Zacks.com
CarMax declines on disappointing sales
Sep 23 / FT.com
Abbott Labs Completes CFR Pharmaceuticals Acquisition - Analyst Blog
10:34am / Zacks.com
Global Tensions and Fear - Ahead of Wall Street
Sep 23 / Zacks.com
Gilead's HCV Combo Drug Harvoni Secures CHMP Backing - Analyst Blog
Sep 29 / Zacks.com
U.S. move on tax-dodging mergers hits drugs stocks
Sep 23 / CNNMoney.com
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog
Sep 26 / Zacks.com
Q&A: US tax inversions
Sep 23 / FT.com
3 Drugs Stocks Driving The Industry Higher
Sep 26 / TheStreet.com
Tax inversion crackdown hits drugmaker shares
Sep 23 / FT.com
Why AbbVie (ABBV) Stock Is Up Today
Sep 26 / TheStreet.com
Stocks: 4 things to know before the open
Sep 23 / CNNMoney.com
3 Reasons AbbVie Inc Stock Could Fall
Sep 26 / MotleyFool.com
Surprising Silver Lining for Gilead Sciences, inc. Stock
Sep 22 / MotleyFool.com
Shire Resolves Litigation Related to Vyvanse, Adderall XR - Analyst Blog
Sep 25 / Zacks.com
Dividend Aristocrats: Time to Buy AbbVie Inc Stock?
Sep 19 / MotleyFool.com
A Better Way To Invest In Alibaba Group Holding Ltd (BABA)?
Sep 25 / Investing Channel
3 Best Stocks to Invest in Pharma
Sep 19 / MotleyFool.com
Gilead (GILD) Seeks Japanese Approval for HCV Combo Drug - Analyst Blog
Sep 24 / Zacks.com
Gilead Down on Weak Simtuzumab Data and Sovaldi News - Analyst Blog
Sep 18 / Zacks.com
Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
Sep 24 / Zacks.com
Europe struggles to catch US biotech bulls
Sep 18 / FT.com
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - A...
Sep 24 / Zacks.com
Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?
Sep 18 / MotleyFool.com
Will New Treasury Rules Contain Tax Inversions? - Analyst Blog
Sep 24 / Zacks.com
Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog
Sep 17 / Zacks.com
Stock Market News for September 24, 2014 - Market News
Sep 24 / Zacks.com
Tax inversion makes a tempting M&A bet
Sep 08 / FT.com
3 Top Dividend Growth Stocks to Buy in October
Sep 24 / MotleyFool.com
Meet the new boss, same as the boss we started with
Sep 05 / FT.com
U.S. Treasury Cracks Down on Tax Inversions - Stocks in the News
Sep 23 / Zacks.com
Levinson move highlights Google health ambitions
Sep 04 / FT.com
Barack Obama's halfhearted swipe at tax inversion
Sep 23 / FT.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.